Germline loss-of-function (LOF) variants in POT1 are associated with a rare oncological predisposition syndrome, known as POT1-tumor predisposition syndrome (POT1-TPD), with no more than 100 affected families currently reported (4). This evidence concerns the gene POT1 and BAP1-related tumor predisposition syndrome.